Guizhou Xinbang Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Guizhou Xinbang Pharmaceutical has a total shareholder equity of CN¥7.2B and total debt of CN¥715.8M, which brings its debt-to-equity ratio to 10%. Its total assets and total liabilities are CN¥9.1B and CN¥2.0B respectively. Guizhou Xinbang Pharmaceutical's EBIT is CN¥388.5M making its interest coverage ratio 34.6. It has cash and short-term investments of CN¥614.0M.
Key information
10.0%
Debt to equity ratio
CN¥715.80m
Debt
| Interest coverage ratio | 34.6x |
| Cash | CN¥613.97m |
| Equity | CN¥7.18b |
| Total liabilities | CN¥1.95b |
| Total assets | CN¥9.13b |
Financial Position Analysis
Short Term Liabilities: 002390's short term assets (CN¥5.3B) exceed its short term liabilities (CN¥1.9B).
Long Term Liabilities: 002390's short term assets (CN¥5.3B) exceed its long term liabilities (CN¥42.4M).
Debt to Equity History and Analysis
Debt Level: 002390's net debt to equity ratio (1.4%) is considered satisfactory.
Reducing Debt: 002390's debt to equity ratio has reduced from 85.5% to 10% over the past 5 years.
Debt Coverage: 002390's debt is well covered by operating cash flow (110.5%).
Interest Coverage: 002390's interest payments on its debt are well covered by EBIT (34.6x coverage).